Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Vajira Hospital, University of Bangkok Metropolitan Administration Medical College, Bangkok, Thailand.
J Gynecol Oncol. 2011 Sep;22(3):145-51. doi: 10.3802/jgo.2011.22.3.145. Epub 2011 Sep 28.
To evaluate the value of visual inspection with acetic acid (VIA) test to detect high grade lesion in women with atypical squamous cells or low grade squamous intraepithelial lesions cervical cytology.
Women with atypical squamous cells or low grade squamous intraepithelial lesions who were scheduled to undergo colposcopy at Vajira Hospital and met inclusion criteria were included. All participants underwent VIA test prior to usual steps of colposcopy. The VIA results were interpreted as positive or negative using the criteria by the International Agency for Cancer Research. The standard colposcopic examination and appropriate investigations for cervical pathology were then continued. The diagnostic values of VIA test including sensitivity, specificity, positive predictive value, and negative predictive value were determined using high grade lesion including cervical intraepithelial neoplasia 2-3 and squamous cell carcinoma as a threshold.
Total of 106 women was included. The VIA test was positive in 33 women (31.1%) and negative in 73 women (68.9%). Among the women with VIA test positive, 14 had high grade lesion (42.4%) while 19 had no significant lesions. Only 2/73 (2.7%) cases with negative VIA test had high grade lesion (both had cervical intraepithelial neoplasia 2). The sensitivity, specificity, positive predictive value and negative predictive value with 95% confidence interval were 87.5% (81.2 to 93.8%), 78.8% (71.1 to 86.7%), 42.4% (33.0 to 51.8%), and 97.2% (94.2 to 1.0%) respectively.
VIA as the intermediate test in atypical squamous cells and low grade squamous intraepithelial lesions cytology may reduce the necessity to refer some women for colposcopy.
评估醋酸视觉检查(VIA)试验在细胞学检查为非典型鳞状细胞或低级别鳞状上皮内病变的女性中检测高级别病变的价值。
选择拟在瓦吉拉医院行阴道镜检查且符合纳入标准的非典型鳞状细胞或低级别鳞状上皮内病变患者。所有参与者在阴道镜检查的常规步骤之前均行 VIA 试验。VIA 结果根据国际癌症研究机构的标准判断为阳性或阴性。然后继续进行标准阴道镜检查和适当的宫颈病理检查。以包括宫颈上皮内瘤变 2-3 级和鳞状细胞癌在内的高级别病变为阈值,确定 VIA 试验的诊断价值,包括敏感性、特异性、阳性预测值和阴性预测值。
共纳入 106 例患者。VIA 试验阳性 33 例(31.1%),阴性 73 例(68.9%)。VIA 试验阳性的女性中,14 例有高级别病变(42.4%),19 例无明显病变。73 例 VIA 试验阴性的女性中仅 2 例(2.7%)有高级别病变(均为宫颈上皮内瘤变 2 级)。VIA 试验的敏感性、特异性、阳性预测值和阴性预测值及其 95%置信区间分别为 87.5%(81.2%93.8%)、78.8%(71.1%86.7%)、42.4%(33.0%51.8%)和 97.2%(94.2%1.0%)。
在细胞学检查为非典型鳞状细胞或低级别鳞状上皮内病变的情况下,VIA 作为中间试验可能减少某些女性行阴道镜检查的必要性。